Network Pharmacological Analyze and Experimental Verification of Lychee Kernel Extract Intervene of Non-alcoholic Fatty Liver Disease

ZHANG Yashuo; A Runa; MA Xinyan; PANG Zongran; LU Binan

doi:10.13386/j.issn1002-0306.2022100271

Volume 44 Issue 18

Sep. 2023

Turn off MathJax

Article Contents

Abstract

References

Science and Technology of Food Industry > 2023 > 44(18): 10-19. > DOI: 10.13386/j.issn1002-0306.2022100271

ZHANG Yashuo, A Runa, MA Xinyan, et al. Network Pharmacological Analyze and Experimental Verification of Lychee Kernel Extract Intervene of Non-alcoholic Fatty Liver Disease[J]. Science and Technology of Food Industry, 2023, 44(18): 10−19. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2022100271.

Citation:

PDF (8058 KB)

Network Pharmacological Analyze and Experimental Verification of Lychee Kernel Extract Intervene of Non-alcoholic Fatty Liver Disease

School of Pharmacy, Minzu University of China, Beijing 100081, China

More Information

Received Date: October 31, 2022
Available Online: July 12, 2023

Graphical Abstract

Abstract

Abstract

Objective: To investigate the effect and potential mechanism of lychee kernel extract in the intervention of non-alcoholic fatty liver disease (Nonalcoholic fatty liver disease, NAFLD) based on network pharmacology. Methods: The components and action targets of litchi nuclei were obtained from the Pharmacology Database and Analysis Platform (TCMSP) within the Chinese Medicine System, the disease targets of NAFLD were obtained using disease target data from GeneCard, the intersection and pathway-target interaction network diagram were obtained through Cytoscape, and the GO bioprocess analysis and KEGG pathway enrichment analysis were performed using Bioinformatics website. This study established an animal model with diet-induced obsisity mouse NAFLD and administered LKE via the gastric route. HE staining indicated lipid changes in the liver. The biological kits detect content of TG, TC, ALT, and AST. Results: Eighteen potential active ingredients of litchi nuclei were identified, and 52 targets intersected with NAFLD disease. The key targets were INS, TNF, and HSP90AA1. KEGG channel enrichment filtered 20 signal pathways, the main ones include: Pathways in cancer, fluid shear stress and atherosclerosis, AGE-RAGE signaling pathway in diabetic complications. The liver lesions of the mice in the model group were severe, the liver lesions of the mice in the drug group were significantly reduced compared with the model group, and the serum transaminases of the mice in the drug group were also significantly reduced, which was close to the normal group, and the blood lipid metabolism of the drug group also tended to be normal group,and the differences were significant (P<0.05). Conclusion: Litchi nuclei might play a role in the treatment of NAFLD by acting on such targets as INS, TNF and HSP90AA1, and modulate lipid and atherosclerotic pathways.
- lychee kernel extract,
- non-alcoholic fatty liver disease,
- network pharmacology,
- DIO mice

FullText(HTML)

References (19)

References

[1]	CHALASANI N, YOUNOSSI Z, LAVINE J E, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the study of liver diseases[J]. Hepatology,2018,67(1):328−357. doi: 10.1002/hep.29367
[2]	王宇威, 刘近春, 安秀琴, 等. 肠道微生态与非酒精性脂肪性肝病研究进展[J]. 中国现代医生,2022,60(15):192−196. [WANG Yuwei, LIU Jinchun, AN Xiuqin, et al. Research progress on intestinal microecology and nonalcoholic fatty liver disease[J]. Modern Chinese Doctor,2022,60(15):192−196. WANG Yuwei, LIU Jinchun, AN Xiuqin, et al. Research progress on intestinal microecology and nonalcoholic fatty liver disease[J]. Modern Chinese Doctor, 2022, 60(15): 192-196.
[3]	LI J, ZOU B, YEO Y H, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: A systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol,2019,4(5):389−398. doi: 10.1016/S2468-1253(19)30039-1
[4]	陈艳, 王珍茹, 张丽, 等. 单纯性脂肪肝患者认知行为现状调查及生活方式干预[J]. 齐鲁护理杂志,2018,24(13):78−81. [CHEN Yan, WANG Zhenru, ZHANG Li, et al. Investigation of cognitive behavior status and lifestyle intervention in patients with simple fatty liver disease[J]. Journal of Qilu Nursing,2018,24(13):78−81. CHEN Yan, WANG Zhenru, ZHANG Li, et al. Investigation of cognitive behavior status and lifestyle intervention in patients with simple fatty liver disease[J]. Journal of Qilu Nursing, 2018, 24(13): 78-81.
[5]	张菊艳, 张萃. 荔枝核化学成分及其药理作用的研究进展[J]. 广东药学院学报,2014,30(6):792−797. [ZHANG Juyan, ZHANG Cui. Research progress on chemical components and pharmacological effects of litchi nucleus[J]. Journal of Guangdong Pharmaceutical University,2014,30(6):792−797. ZHANG Juyan, ZHANG Cui. Research progress on chemical components and pharmacological effects of litchi nucleus[J]. Journal of Guangdong Pharmaceutical University, 2014, 30(6): 792-797.
[6]	张雅馨, 冯茵怡, 梁健钦, 等. 荔枝核的化学成分及治疗肝病的作用机制研究进展[J]. 广西中医药大学学报,2021,24(2):84−87. [ZHANG Yaxin, FENG Yinyi, LIANG Jianqin, et al. Research progress on chemical composition of lychee nucleus and mechanism of action in the treatment of liver disease[J]. Journal of Guangxi University of Chinese Medicine,2021,24(2):84−87. ZHANG Yaxin, FENG Yinyi, LIANG Jianqin, et al. Research progress on chemical composition of lychee nucleus and mechanism of action in the treatment of liver disease[J]. Journal of Guangxi University of Chinese Medicine, 2021, 24(2): 84-87.
[7]	张巍, 甘宏发, 蔡怡婷, 等. 荔枝核提取物对非酒精性脂肪性肝炎大鼠肝组织巨噬细胞移动抑制因子表达的影响[J]. 中西医结合肝病杂志,2011,21(1):24−26. [ZHANG Wei, GAN Hongfa, CAI Yiting, et al. Effect of litchi nucleus extract on expression of macrophage movement inhibitor in liver tissue of rats with nonalcoholic steatohepatitis[J]. Journal of Integrative Medicine and Liver Disease,2011,21(1):24−26. ZHANG Wei, GAN Hongfa, CAI Yiting, et al. Effect of litchi nucleus extract on expression of macrophage movement inhibitor in liver tissue of rats with nonalcoholic steatohepatitis[J]. Journal of Integrative Medicine and Liver Disease, 2011, 21(1): 24-26.
[8]	柏林宇, 曾惠娜, 巫秀美, 等. 康复新液促进创伤修复的网络药理学研究[J]. 广东化工,2022,49(8):55−58. [BO linyu, ZENG Huina, WU Xiumei, et al. Network pharmacology of new rehabilitation fluid for promoting wound repair[J]. Guangdong Chemical Industry,2022,49(8):55−58. BO linyu, ZENG Huina, WU Xiumei, et al. Network pharmacology of new rehabilitation fluid for promoting wound repair[J]. Guangdong Chemical Industry, 2022, 49(8): 55-58.
[9]	LI S, ZHANG B. Traditional Chinese medicine network pharmacology: Theory, methodology and application[J]. Chin J Nat Med,2013,11(2):110−120.
[10]	RU J, LI P, WANG J, et al. TCMSP: A database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform,2014,6:13. doi: 10.1186/1758-2946-6-13
[11]	林嘉荣, 郑慰武, 曾贵兴, 等. 金花清感颗粒治疗新型冠状病毒肺炎网络药理学的研究[J]. 中药材,2020,43(8):2070−2076. [LIN Jiarong, ZHENG Weiwu, ZENG Guixing, et al. Research on network pharmacology of Jinhua Qinggan granules in the treatment of novel coronavirus pneumonia[J]. Chinese Materia Medica,2020,43(8):2070−2076. LIN Jiarong, ZHENG Weiwu, ZENG Guixing, et al. Research on network pharmacology of Jinhua Qinggan granules in the treatment of novel coronavirus pneumonia[J]. Chinese Materia Medica, 2020, 43(8): 2070-2076.
[12]	SZKLARCZYK D, MORRIS J H, COOK H, et al. The STRING database in 2017: Quality-controlled protein-protein association networks, made broadly accessible[J]. Nucleic Acids Res,2017,45(D1):D362−D368. doi: 10.1093/nar/gkw937
[13]	李玉凤, 丁世磊, 赵立春. 基于网络药理学探讨荔枝核抗炎作用机制[J]. 特产研究,2021,43(3):50−58. [LI Yufeng, DING Shilei, ZHAO Lichun. Discussion on the anti-inflammatory mechanism of litchi nucleus based on network pharmacology[J]. Specialty Research,2021,43(3):50−58. LI Yufeng, DING Shilei, ZHAO Lichun. Discussion on the anti-inflammatory mechanism of litchi nucleus based on network pharmacology[J]. Specialty Research, 2021, 43(3): 50-58.
[14]	ROOS J, ZINNGREBE J, FISCHER-POSOVSZKY P. Nicotinamide mononucleotide: A potential effective natural compound against insulin resistance[J]. Signal Transduct Target Ther,2021,6(1):310. doi: 10.1038/s41392-021-00723-z
[15]	许萍, 黄淑芸, 郭红敏, 等. 安石榴苷治疗抑郁症的网络药理学研究及实验验证[J]. 中国药理学通报,2022,38(5):755−760. [XU Ping, HUANG Shuyun, GUO Hongmin, et al. Network pharmacology and experimental verification of anpomegranate glycoside in the treatment of depression[J]. Chinese Pharmacological Bulletin,2022,38(5):755−760. XU Ping, HUANG Shuyun, GUO Hongmin, et al. Network pharmacology and experimental verification of anpomegranate glycoside in the treatment of depression[J]. Chinese Pharmacological Bulletin, 2022, 38(5): 755-760.
[16]	LEE S R, LEE H J, CHOI E K, et al. Direct oral anticoagulants in patients with atrial fibrillation and liver disease[J]. J Am Coll Cardiol,2019,73(25):3295−3308. doi: 10.1016/j.jacc.2019.04.052
[17]	PHANIENDRA A, JESTADI D B, PERIYASAMY L. Free radicals: Properties, sources, targets, and their implication in various diseases[J]. Indian J Clin Biochem,2015,30(1):11−26. doi: 10.1007/s12291-014-0446-0
[18]	RICHARD D, KEFI K, BARBE U, et al. Polyunsaturated fatty acids as antioxidants[J]. Pharmacol Res,2008,57(6):451−455. doi: 10.1016/j.phrs.2008.05.002
[19]	薛亚梅, 金建远, 李坤. 精子DNA碎片与HSP90AA1基因多态性的相关性研究[J]. 全科医学临床与教育,2019,17(9):781−784. [XUE Yamei, JIN Jianyuan, LI Kun. Correlation between sperm DNA fragmentation and HSP90AA1 gene polymorphism[J]. Clinical and Education of General Practice,2019,17(9):781−784. XUE Yamei, JIN Jianyuan, LI Kun. Correlation between sperm DNA fragmentation and HSP90AA1 gene polymorphism[J]. Clinical and Education of General Practice, 2019, 17(9): 781-784.

Supplements (0)

Cited By

Cited by

Periodical cited type(4)

1.	杨朴丽，刘忠妹，许木果，丰玉云，张阳梅，赵志平. 西番莲研究进展. 热带农业科技. 2024(01): 17-22 .
2.	杨子逸，王玉荣，王振宇，王子敬，刘立成. 山楂枸杞复合果汁悬浮和色泽稳定性的研究. 保鲜与加工. 2024(09): 95-101 .
3.	王润峥，王勇，刘炳浩，刘素稳，程玉豆，常学东. 桃果汁护色澄清技术研究进展与发展趋势. 河北果树. 2023(01): 1-2+5 .
4.	周小伟，程金生，易道生，吴炜妍. 百香果仙草饮料配方研究. 韶关学院学报. 2023(12): 1-6 .